𝔖 Bobbio Scriptorium
✦   LIBER   ✦

24. Levodopa response and P300 in patients with Parkinson’s disease

✍ Scribed by Norihiko Kodama; Hisao Tachibana; Keita Kawabata; Naomi Shibuya; Hideto Kitano; Tomoko Oku

Book ID
119216830
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
36 KB
Volume
119
Category
Article
ISSN
1388-2457

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Levodopa response in early Parkinson's d
Levodopa response in early Parkinson's disease
✍ Robert A. Hauser; Peggy Auinger; David Oakes 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 1 views

## Abstract To further characterize the short‐term levodopa response in early PD, we performed a retrospective analysis of the ELLDOPA study which randomized 361 early PD subjects to placebo, levodopa 150, 300, or 600 mg/day. We evaluated change in UPDRS motor scores (UPDRSm) from baseline to weeks

Cysteine elevation in levodopa-treated p
Cysteine elevation in levodopa-treated patients with Parkinson's disease
✍ Thomas Müller; Wilfried Kuhn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB 👁 1 views

## Abstract Homocysteine, cysteine, and cysteinyl‐glycine are all metabolically interrelated. Levodopa/decarboxylase inhibitor (LD/DCI) administration increases total homocysteine (tHcy) plasma levels. Objectives were to investigate associations between LD/DCI intake, concentrations of tHcy, cystei

Hyperhomocysteinemia in levodopa-treated
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia
✍ Stefano Zoccolella; Claudia dell'Aquila; Giovanni Abruzzese; Angelo Antonini; Ub 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

## Abstract Dementia is a frequent non‐motor feature of Parkinson's disease (PD). Elevated plasma homocysteine (Hcy) levels have been associated with both cognitive impairment and dementia. Increased Hcy levels have been observed in levodopa‐treated patients with PD. The objective of our study was